Skip Navigation

European Heart Journal 2002 23(16):1237-1239; doi:10.1053/euhj.2002.3184
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Whynes, D.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whynes, D.K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Health care costs ...

D.K. Whynes

School of Economics, University of Nottingham, Nottingham, U.K.

References

  1. Nord E, Richardson J, Street A, Kuhse H, Singer P. Who cares about cost? Health Policy. 1995;34:79–94[CrossRef][Web of Science][Medline]
  2. Raftery J. Costing in economic evaluation. Br Med J. 2000;320:1597[Free Full Text]
  3. Koopmanschap MA, Touw KCR, Rutten FFH. Analysis of costs and cost-effectiveness in multinational trials. Health Policy. 2001;58:175–186[CrossRef][Web of Science][Medline]
  4. Barber JA, Thompson SG. Analysis and interpretation of cost data in randomised controlled trials: review of published studies. Br Med J. 1998;317:1195–1200[Abstract/Free Full Text]
  5. Johnston K, Buxton MJ, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Tech Assess. 1999;3:1–76
  6. Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 1997.
  7. Schulpher MJ, Smith DH, Clayton T. Coronary angioplasty versus medical therapy for angina: health service costs based on the second Randomised Intervention Treatment of Angina (RITA-2) trial. Eur Heart J. 2002;23:1289–1298
  8. Hlatky MA, Bigger T. Cost-effectiveness of the implantable cardioverter defibrillator? Lancet. 2001;357:1817[CrossRef][Web of Science][Medline]
  9. Zipes DP. Implantable cardioverter-defibrillator: a Volkswagen or a Rolls Royce: how much will we pay to save a life? Circulation. 2001;103:1372–1374[Free Full Text]
  10. Coyle D, Drummond MF. Analyzing differences in the costs of treatment across centres within economic evaluations. Int J Tech Assess Health Care. 2001;17:155–163[CrossRef]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Whynes, D.K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whynes, D.K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?